LB PHARMACEUTICALS INC (LBRX) Stock Analyst Ratings
USA - NASDAQ:LBRX - US50180M1080 - Common Stock
15.98 USD
+1.37 (+9.38%)
15.98 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to LBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.26. This target is 195.74% above the current price.
LBRX was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LBRX.
LBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-06 | Leerink Partners | Initiate | Outperform |
| 2025-10-06 | Stifel | Initiate | Buy |
| 2025-10-06 | Piper Sandler | Initiate | Overweight |
LB PHARMACEUTICALS INC / LBRX FAQ
What is the price target for LBRX stock?
9 analysts have analysed LBRX and the average price target is 47.26 USD. This implies a price increase of 195.74% is expected in the next year compared to the current price of 15.98.
What is the consensus rating for LB PHARMACEUTICALS INC (LBRX) stock?
The consensus rating for LB PHARMACEUTICALS INC (LBRX) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.